相关实验视频

Updated: Jul 12, 2025

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG

Published on: March 7, 2017

小儿二脑瘤的新型治疗方法:改善功能结果

Julia V Cockle^1,2, Elizabeth A Corley³, Bassel Zebian⁴

¹Department of Neuro-oncology, Children and Young People's Unit, The Royal Marsden National Health Service (NHS) Foundation Trust, London, United Kingdom.

Frontiers in oncology

|October 27, 2023

概括

儿科二脑瘤是多样化的脑瘤,需要多学科的护理. 本综述涵盖了它们的特点,并强调了功能维护策略,以获得更好的结果.

科学领域:

神经瘤学神经瘤学
儿科病理学儿科病理学
内分泌学在内分泌学.

背景情况:

儿童脑膜瘤是一种复杂的新生体.
它们会影响关键的大脑结构,如下丘脑-垂体轴 (HPA) 和视觉通路.
症状可以是神经,内分泌或视觉的,需要谨慎管理.

研究的目的:

审查儿科二脑瘤的临床和病理特征.
讨论这些瘤的当前管理策略.
突出转向功能维护和毒性节约方法的转变.

主要方法:

关于儿科二脑瘤的文献综述.
临床表现和病理学分类的分析.
对诊断和治疗策略的评估.

主要成果:

儿科二脑瘤表现出显著的组织病理学和分子多样性.
早期,协调的多学科评估对于最佳结果至关重要.
人们越来越重视功能维护干预措施.

结论:

儿童二脑瘤的有效管理需要一个全面的,多学科的方法.
新的治疗策略旨在尽量减少毒性,同时保持功能.
对向治疗的持续研究对于改善患者的治疗结果至关重要.

关键词:

兰格汉斯细胞的基细胞分裂这种瘤叫做craniopharyngioma.功能性结果的结果.胚胎细胞瘤的发生.质瘤质瘤是一种分子向疗法是指分子向疗法.儿科二脑瘤儿科二脑瘤

更多相关视频

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization

Published on: September 20, 2024

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice

Published on: February 24, 2023

相关概念视频

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...